YANIMO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator)

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

olodaterol hydrochloride, Quantity: 2.736 microgram/actuation (Equivalent: olodaterol, Qty 2.5 microgram/actuation); tiotropium bromide monohydrate, Quantity: 3.124 microgram/actuation (Equivalent: tiotropium, Qty 2.5 microgram/actuation)

Commercializzato da:

Boehringer Ingelheim Pty Ltd

Forma farmaceutica:

Inhalation, conventional

Composizione:

Excipient Ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate

Via di somministrazione:

Inhalation

Confezione:

3 x 1 cartridge (60 metered actuations) with dose indicator, 1 cartridge (60 metered actuations) with dose indicator

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

YANIMO RESPIMAT is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

Dettagli prodotto:

Visual Identification: Clear, colourless solution.; Container Type: Cartridge; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2020-03-04